| A comparison of McGrath and Macintosh laryngoscopes in novice users: a manikin study DC Ray, C Billington, PK Kearns, R Kirkbride, K Mackintosh, CS Reeve, ... Anaesthesia 64 (11), 1207-1210, 2009 | 152 | 2009 |
| Viral etiology of hospitalized acute lower respiratory infections in children under 5 years of age–a systematic review and meta-analysis I Lukšić, PK Kearns, F Scott, I Rudan, H Campbell, H Nair Croatian medical journal 54 (2), 122-134, 2013 | 90 | 2013 |
| The benefits of a peer‐assisted mock OSCE I Young, K Montgomery, P Kearns, S Hayward, E Mellanby The clinical teacher 11 (3), 214-218, 2014 | 81 | 2014 |
| Systematic review of prediction models in relapsing remitting multiple sclerosis FS Brown, SA Glasmacher, PKA Kearns, N MacDougall, D Hunt, ... PLoS One 15 (5), e0233575, 2020 | 42 | 2020 |
| Regional variation in the incidence rate and sex ratio of multiple sclerosis in Scotland 2010–2017: findings from the Scottish Multiple Sclerosis Register PKA Kearns, M Paton, M O’Neill, C Waters, S Colville, J McDonald, ... Journal of Neurology 266, 2376-2386, 2019 | 38 | 2019 |
| Questioning the regressivity of tobacco taxes: a distributional accounting impact model of increased tobacco taxation S Verguet, PKA Kearns, VW Rees Tobacco Control 30 (3), 245-257, 2021 | 22 | 2021 |
| Transplantation between monozygotic twins: how identical are they? E Day, PK Kearns, CJ Taylor, JA Bradley Transplantation 98 (5), 485-489, 2014 | 21 | 2014 |
| Non‐invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh Type 2 Diabetes Study SM Grecian, S McLachlan, JA Fallowfield, PKA Kearns, PC Hayes, ... Liver International 40 (9), 2252-2262, 2020 | 19 | 2020 |
| Impact of the first COVID-19 pandemic wave on the Scottish Multiple Sclerosis Register population PM Fernandes, M O'neill, PKA Kearns, S Pizzo, C Watters, S Baird, ... Wellcome Open Research 5, 2020 | 19 | 2020 |
| Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing-remitting … R Meijboom, SJ Wiseman, EN York, ME Bastin, MCV Hernández, ... Wellcome Open Research 7, 2022 | 15 | 2022 |
| Hypothesis: Multiple sclerosis is caused by three-hits, strictly in order, in genetically susceptible persons PKA Kearns, HA Casey, JP Leach Multiple Sclerosis and Related Disorders 24, 157-174, 2018 | 15 | 2018 |
| MRI-derived g-ratio and lesion severity in newly diagnosed multiple sclerosis EN York, SJ Martin, R Meijboom, MJ Thrippleton, ME Bastin, E Carter, ... Brain Communications 3 (4), fcab249, 2021 | 14 | 2021 |
| FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis PKA Kearns, SJ Martin, J Chang, R Meijboom, EN York, Y Chen, ... BMJ open 12 (6), e058506, 2022 | 10 | 2022 |
| The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland SA Glasmacher, J Larraz, AR Mehta, PKA Kearns, M Wong, J Newton, ... Journal of Neurology 268, 2038-2040, 2021 | 9 | 2021 |
| Network analysis characterizes key associations between subjective fatigue and specific depressive symptoms in early relapsing-remitting multiple sclerosis YT Chang, PKA Kearns, A Carson, DC Gillespie, R Meijboom, A Kampaite, ... Multiple Sclerosis and Related Disorders 69, 104429, 2023 | 7 | 2023 |
| The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosis SA Glasmacher, PKA Kearns, Z Hassan, P Connick, S Tauber, K Reetz, ... Multiple Sclerosis and Related Disorders 63, 103837, 2022 | 6 | 2022 |
| The benefits of a peer-assisted mock OSCE. Clin Teach. 2014; 11 (3): 214–8 I Young, K Montgomery, P Kearns, S Hayward, E Mellanby | 6 | |
| Prevention of MS requires intervention on the causes of the disease: Reconciling genes, epigenetics, and Epstein Barr virus PKA Kearns Frontiers in Neurology 13, 817677, 2022 | 3 | 2022 |
| Data-driven analysis shows robust links between fatigue and depression in early multiple sclerosis YT Chang, PKA Kearns, A Carson, DC Gillespie, R Meijboom, A Kampaite, ... medRxiv, 2022.01. 13.22269128, 2022 | 2 | 2022 |
| Prevalence of multimorbidity and its impact on survival in people with motor neuron disease SA Glasmacher, PKA Kearns, J Larraz, L Stirland, AR Mehta, J Newton, ... European Journal of Neurology 28 (8), 2756-2765, 2021 | 2 | 2021 |
